Full Text View
Tabular View
No Study Results Posted
Related Studies
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
This study has been completed.
Study NCT00003582   Information provided by University of Miami Sylvester Comprehensive Cancer Center

First Received on November 1, 1999.   Last Updated on April 15, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Carcinoma of Unknown Primary
Head and Neck Cancer
Additional conditions recognized in this trial
Carcinoma
Head and Neck Neoplasms
Neoplasms, Unknown Primary
More general conditions related to this trial
Neoplasm Metastasis
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplastic Processes
Pathologic Processes
Interventions listed in this trial
amifostine trihydrate
cisplatin
fluorouracil
paclitaxel
quality-of-life assessment
radiation therapy
Additional drug interventions recognized in this trial
Amifostine
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Radiation-Sensitizing Agents
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
University of Miami Sylvester Comprehensive Cancer Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services